Literature DB >> 16513463

Novel mutations in the OPA1 gene and associated clinical features in Japanese patients with optic atrophy.

Makoto Nakamura1, Jian Lin, Shinji Ueno, Ryo Asaoka, Toshie Hirai, Yoshihiro Hotta, Yozo Miyake, Hiroko Terasaki.   

Abstract

PURPOSE: Autosomal dominant optic atrophy (ADOA) is characterized by symmetrical bilateral optic atrophy associated with reduced corrected visual acuity (VA), central or centrocecal scotoma, and color vision disturbances. The disease is genetically heterogeneous, and the OPA1 gene has been identified as the only causative gene. The aims of this study were to identify and report mutations in the OPA1 gene in Japanese patients with ADOA and to describe the clinical features associated with the mutations.
DESIGN: Molecular genetic study and observational case reports. PARTICIPANTS: Nine unrelated Japanese families with optic atrophy and 8 isolated cases of optic atrophy.
METHODS: Genomic DNA was extracted from peripheral leukocytes, and all exons containing the open reading frame of the OPA1 gene and the flanking intron splice sites were sequenced directly. Complete ophthalmologic examinations were performed. MAIN OUTCOME MEASURES: Direct sequencing of the OPA1 gene and clinical evaluations including VA, visual field, color vision, and disc appearance.
RESULTS: Ten different heterozygous mutations, including 6 novel mutations, were detected in the OPA1 gene. The identified mutations included 5 deletions/insertions (c.2061delA, c.2098_2103delCTTAAA, c.2538insT, c.2591insC, and c.2708_2711delTTAG), 4 nonsense mutations (c.112C>T [p.R38X], c.181C>T [p.Q61X], c.946A>T [p.R316X], and c.2713C>T [p.R905X]), and 1 missense mutation (c.1635C>A [p.S545R]). The most common mutation in Caucasians (c.2708_2711delTTAG) was found in 3 unrelated families, suggesting that it is a mutational hot spot. We detected an OPA1 mutation in 8 of 9 familial cases of optic atrophy and in 4 of 8 cases that were initially considered to be sporadic from the patients' family histories. Examinations of family members of 2 sporadic probands revealed the existence of other family members with the OPA1 mutations whose phenotype was very mild or within normal limits. This indicates that patients with ADOA sometimes seem to be sporadic because of the extensive variation in the phenotype or, alternatively, a low penetrance of ADOA.
CONCLUSIONS: OPA1 gene mutations are causative in most familial cases of ADOA in Japanese. Sporadic cases of optic atrophy frequently may be caused by OPA1 mutations in the Japanese population. Molecular genetic examinations are useful in determining the hereditary patterns in some cases of optic atrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513463     DOI: 10.1016/j.ophtha.2005.10.054

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  OPA1 mutations in Japanese patients suspected to have autosomal dominant optic atrophy.

Authors:  Tetsuya Hamahata; Takuro Fujimaki; Keiko Fujiki; Ai Miyazaki; Atsushi Mizota; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2011-11-01       Impact factor: 2.447

2.  A novel mutation of the OPA1 gene in a Japanese patient with autosomal dominant optic atrophy.

Authors:  Yuriko Ban; Yusuke Yoshida; Satoshi Kawasaki; Chikako Mochida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-06-20       Impact factor: 3.117

Review 3.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

4.  Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy.

Authors:  Takaaki Hayashi; Hiroyuki Sasano; Satoshi Katagiri; Kazushige Tsunoda; Shuhei Kameya; Mitsuru Nakazawa; Takeshi Iwata; Hiroshi Tsuneoka
Journal:  Jpn J Ophthalmol       Date:  2017-07-01       Impact factor: 2.447

5.  Diagnostic genetic testing for patients with bilateral optic neuropathy and comparison of clinical features according to OPA1 mutation status.

Authors:  Eric D Gaier; Katherine Boudreault; Isao Nakata; Maria Janessian; Philip Skidd; Elizabeth DelBono; Keri F Allen; Louis R Pasquale; Emily Place; Dean M Cestari; Rebecca C Stacy; Joseph F Rizzo; Janey L Wiggs
Journal:  Mol Vis       Date:  2017-08-10       Impact factor: 2.367

6.  Autosomal dominant optic atrophy caused by six novel pathogenic OPA1 variants and genotype-phenotype correlation analysis.

Authors:  Jinfeng Han; Ya Li; Ya You; Ke Fan; Bo Lei
Journal:  BMC Ophthalmol       Date:  2022-07-26       Impact factor: 2.086

7.  Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.

Authors:  Yabin Chen; Xiaoyun Jia; Panfeng Wang; Xueshan Xiao; Shiqiang Li; Xiangming Guo; Qingjiong Zhang
Journal:  Mol Vis       Date:  2013-02-06       Impact factor: 2.367

8.  Dominant optic atrophy in Denmark - report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90%.

Authors:  Gitte J Almind; Jakob Ek; Thomas Rosenberg; Hans Eiberg; Michael Larsen; Lucamp Lucamp; Karen Brøndum-Nielsen; Karen Grønskov
Journal:  BMC Med Genet       Date:  2012-08-02       Impact factor: 2.103

9.  Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy.

Authors:  Jian-Kang Li; Wei Li; Feng-Juan Gao; Shou-Fang Qu; Fang-Yuan Hu; Sheng-Hai Zhang; Li-Li Li; Zi-Wei Wang; Yong Qiu; Lu-Sheng Wang; Jie Huang; Ji-Hong Wu; Fang Chen
Journal:  Transl Vis Sci Technol       Date:  2020-07-08       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.